Back to Authors

Nag, Radhakanta

https://orcid.org/0000-0001-8456-5487

Mayo Clinic

Odisha University of Agriculture and Technology

Citations 1

Molecular Susceptibility and Treatment Challenges in Melanoma
Kolathur, Kiran Kumar , Nag, Radhakanta , Shenoy, P. , Malik, Yagya, Varanasi, Sai Manasa , Angom, Ramcharan Singh , Mukhopadhyay, Debabrata , Shenoy, Prathvi V , Mukhopadhyay, Debabrata , Singh Angom, Ramcharan

Cells | August 20, 2024 | Volume: 13 | Issue: 16 | Pages: 1383

10.3390/cells13161383 Get It

Melanoma is the most aggressive subtype of cancer, with a higher propensity to spread compared to most solid tumors. The application of OMICS approaches has revolutionized the field of melanoma research by providing comprehensive insights into the molecular alterations and biological processes underlying melanoma development and progression. This review aims to offer an overview of melanoma biology, covering its transition from primary to malignant melanoma, as well as the key genes and pathways involved in the initiation and progression of this disease. Utilizing online databases, we extensively explored the general expression profile of genes, identified the most frequently altered genes and gene mutations, and examined genetic alterations responsible for drug resistance. Additionally, we studied the mechanisms responsible for immune checkpoint inhibitor resistance in melanoma.